Critical Care Evidence Updates – September 2022
The Bottom Line,
What’s new in the Critical Care literature – monthly updates
Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial
Overview of attention for article published in The Lancet Respiratory Medicine, September 2022
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (96th percentile)
-
Good Attention Score compared to outputs of the same age and source (75th percentile)
Mentioned by
- news
- 3 news outlets
- blogs
- 2 blogs
- 32 X users
- wikipedia
- 2 Wikipedia pages
- 1 Redditor
Readers on
- mendeley
- 57 Mendeley